Documents
Application Sponsors
NDA 018484 | PHARMACIA AND UPJOHN | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 0.5MG/ML | 1 | PROSTIN VR PEDIATRIC | ALPROSTADIL |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1981-10-16 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1987-10-28 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1988-03-31 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1986-04-14 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 5 | AP | 1987-07-10 | |
LABELING; Labeling | SUPPL | 6 | AP | 1990-03-28 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1992-02-11 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1995-01-10 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1993-01-26 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 1994-05-04 | PRIORITY |
LABELING; Labeling | SUPPL | 11 | AP | 1993-06-26 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 1994-06-15 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 14 | AP | 2000-04-03 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 15 | AP | 2001-08-13 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 16 | AP | 2002-05-01 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 17 | AP | 2002-12-17 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 26 | AP | 2014-06-09 | PRIORITY |
LABELING; Labeling | SUPPL | 28 | AP | 2019-07-18 | STANDARD |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 0 |
SUPPL | 14 | Null | 0 |
SUPPL | 15 | Null | 0 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 0 |
SUPPL | 26 | Null | 0 |
SUPPL | 28 | Null | 15 |
TE Codes
CDER Filings
PFIZER
cder:Array
(
[0] => Array
(
[ApplNo] => 18484
[companyName] => PFIZER
[docInserts] => ["",""]
[products] => [{"drugName":"PROSTIN VR PEDIATRIC","activeIngredients":"ALPROSTADIL","strength":"0.5MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"07\/18\/2019","submission":"SUPPL-28","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/018484Orig1s028lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"PROSTIN VR PEDIATRIC","submission":"ALPROSTADIL","actionType":"0.5MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-07-18
)
)